LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6K | Hold |
1,803
| – | – | ﹤0.01% | 478 |
|
|
2025
Q1 | $9.12K | Hold |
1,803
| – | – | ﹤0.01% | 487 |
|
|
2024
Q4 | $6.29K | Hold |
1,803
| – | – | ﹤0.01% | 502 |
|
|
2024
Q3 | $8.84K | Hold |
1,803
| – | – | ﹤0.01% | 503 |
|
|
2024
Q2 | $4.26K | Hold |
1,803
| – | – | ﹤0.01% | 523 |
|
|
2024
Q1 | $3.57K | Hold |
1,803
| – | – | ﹤0.01% | 539 |
|
|
2023
Q4 | $28.8K | Hold |
1,803
| – | – | ﹤0.01% | 436 |
|
|
2023
Q3 | $32.5K | Hold |
1,803
| – | – | ﹤0.01% | 454 |
|
|
2023
Q2 | $38.9K | Buy |
+1,803
| New | +$38.9K | ﹤0.01% | 451 |
|
|
2022
Q4 | – | Sell |
-1,803
| Closed | -$51K | – | 577 |
|
|
2022
Q3 | $51K | Buy |
+1,803
| New | +$51K | ﹤0.01% | 406 |
|